These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 3159632)

  • 1. An overview of antiplatelet and antithrombotic drugs.
    Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB
    Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacologic and dietary management of prostaglandin synthesis in the prevention of thrombosis].
    Carreras LO
    Sangre (Barc); 1982; 27(2):198-217. PubMed ID: 6289481
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemostasis, thrombosis, and thromboembolic disorders. The role of arachidonic acid metabolites in platelet-vessel wall interactions.
    Harlan JM; Harker LA
    Med Clin North Am; 1981 Jul; 65(4):855-80. PubMed ID: 6792433
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of action of antiplatelet medication].
    Navarro JL; Frade FJ; Alava I; Obispo T; Trejo R; Jiménez C; Cesar J
    Sangre (Barc); 1984; 29(4-C):817-32. PubMed ID: 6096974
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostaglandins and hemostasis: an overview.
    Stuart MJ
    Adv Pediatr; 1983; 30():321-64. PubMed ID: 6231843
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction of thrombin and platelets with the vascular endothelium.
    Hoak JC; Czervionke RL; Fry GL; Smith JB
    Fed Proc; 1980 Jul; 39(9):2606-9. PubMed ID: 6995153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 8. Current issues in thrombosis prevention with antiplatelet drugs.
    de Gaetano G; Cerletti C; Dejana E; Vermylen J
    Drugs; 1986 Jun; 31(6):517-49. PubMed ID: 3525085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 10. Normal mechanisms of platelet function.
    Vermylen J; Badenhorst PN; Deckmyn H; Arnout J
    Clin Haematol; 1983 Feb; 12(1):107-51. PubMed ID: 6301715
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanisms of action of prostaglandins on the thrombocyte-vascular wall system].
    Gabrielian ES; Akopov SE; Badzhinian SA
    Vestn Akad Med Nauk SSSR; 1984; (11):63-8. PubMed ID: 6099016
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandins and prostaglandin inhibitors in ischemic heart disease.
    Pitt B; Shea MJ; Romson JL; Lucchesi BR
    Ann Intern Med; 1983 Jul; 99(1):83-92. PubMed ID: 6407379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
    De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
    Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin in physiology and pathophysiology.
    Vane JR; Bunting S; Moncada S
    Int Rev Exp Pathol; 1982; 23():161-207. PubMed ID: 6806207
    [No Abstract]   [Full Text] [Related]  

  • 15. Biologic interaction of prostaglandin, thromboxane and prostacyclin: potential clinical applications.
    Bell TG; Smith WL; Oxender WD
    J Environ Pathol Toxicol Oncol; 1986; 6(3-4):191-201. PubMed ID: 3012063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin.
    Moncada S
    Br J Pharmacol; 1982 May; 76(1):3-31. PubMed ID: 7044460
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of hemostatic and fibrinolytic changes in thrombus formation in cardiovascular diseases].
    Andreenko GV
    Kardiologiia; 1981 Aug; 21(8):120-5. PubMed ID: 7026866
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of prostacyclin and thromboxane A2 in the cardiovascular system].
    Ismailov ShI; Val'dman AV
    Kardiologiia; 1981 Mar; 21(3):111-6. PubMed ID: 7014974
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
    Baluda VP; Sushkevich GN; Lukoianova TI
    Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antithrombotic agents, pharmacologic principles].
    Markwardt F
    Z Arztl Fortbild (Jena); 1986; 80(14):565-70. PubMed ID: 3765695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.